The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhang, W., Chen, B., Jin, J., He, Y., & Niu, Y.-Q. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.776681 · Cited by 8
RetractedWalker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Long noncoding RNAs: functional surprises from the RNA world
Wilusz, J. E., Sunwoo, H., & Spector, D. L. (2009) · Genes & Development · doi:10.1101/gad.1800909 · Cited by 2,294
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,386
miRNAs, Cancer, and Stem Cell Division
Croce, C. M., & Calin, G. A. (2005) · Cell · doi:10.1016/j.cell.2005.06.036 · Cited by 1,329
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,231
Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.009 · Cited by 1,073
ABC Multidrug Transporters: Structure, Function and Role in Chemoresistance
Sharom, F. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.1.105 · Cited by 973
Kathawala, R. J., Gupta, P., Ashby, C. R., & Chen, Z.-S. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2014.11.002 · Cited by 777
Self-citationMulti-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
Wu, Q., Yang, Z., Nie, Y., Shi, Y., & Fan, D. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.03.013 · Cited by 776
Deeley, R. G., Westlake, C., & Cole, S. P. C. (2006) · Physiological Reviews · doi:10.1152/physrev.00035.2005 · Cited by 761 · cited 1×
“ABC transporters can be classified on the basis of the structure and sequence of the NBDs, also known as ABC domains [19,20].”
Mechanisms of Multidrug Resistance in Cancer
Gillet, J.-P., & Gottesman, M. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 685
Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
Mao, Q., & Unadkat, J. D. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9668-6 · Cited by 670
Büchler, M., König, J., Brom, M., Kartenbeck, J., Spring, H., Horie, T., & Keppler, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15091 · Cited by 638
Kovalchuk, O., Filkowski, J., Meservy, J., Ilnytskyy, Y., Tryndyak, V. P., Chekhun, V. F., & Pogribny, I. P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0021 · Cited by 635
ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Choi, Y., & Yu, A.-M. (2014) · Current Pharmaceutical Design · doi:10.2174/138161282005140214165212 · Cited by 629
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
Zhou, S.-F. (2008) · Xenobiotica · doi:10.1080/00498250701867889 · Cited by 599
Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
König, J., Müller, F., & Fromm, M. F. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007518 · Cited by 575
The P-glycoprotein multidrug transporter
Sharom, F. J. (2011) · Essays in Biochemistry · doi:10.1042/bse0500161 · Cited by 509
Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
Shapira, A., Livney, Y. D., Broxterman, H. J., & Assaraf, Y. G. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.01.003 · Cited by 504
Multiple Drug Resistance Mechanisms in Cancer
Baguley, B. C. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9321-2 · Cited by 478
Zhu, H., Wu, H., Liu, X., Evans, B. R., Medina, D. J., Liu, C.-G., & Yang, J.-M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.007 · Cited by 456
List, A. F., Kopecky, K. J., Willman, C. L., Head, D. R., Persons, D. L., Slovak, M. L., Dorr, R., Karanes, C., Hynes, H. E., Doroshow, J. H., et al. (2001) · Blood · doi:10.1182/blood.v98.12.3212 · Cited by 419
Choudhuri, S., & Klaassen, C. D. (2006) · International Journal of Toxicology · doi:10.1080/10915810600746023 · Cited by 415
An overview of cancer multidrug resistance: a still unsolved problem
Lage, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8111-5 · Cited by 408
The apical conjugate efflux pump ABCC2 (MRP2)
Nies, A. T., & Keppler, D. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0109-y · Cited by 398
Binkhathlan, Z., & Lavasanifar, A. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113139990076 · Cited by 390
Structural diversity of ABC transporters
ter Beek, J., Guskov, A., & Slotboom, D. J. (2014) · Journal of General Physiology · doi:10.1085/jgp.201411164 · Cited by 384
Drugs as P-glycoprotein substrates, inhibitors, and inducers
Kim, R. B. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001389 · Cited by 382
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Silva, R., Vilas-Boas, V., Carmo, H., Dinis-Oliveira, R. J., Carvalho, F., de Lourdes Bastos, M., & Remião, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.013 · Cited by 339
Expression of members of the multidrug resistance protein family in human term placenta
St-Pierre, M. V., Serrano, M. A., Macias, R. I. R., Dubs, U., Hoechli, M., Lauper, U., Meier, P. J., & Marin, J. J. G. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.4.r1495 · Cited by 325
P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
Abdallah, H. M., Al-Abd, A. M., El-Dine, R. S., & El-Halawany, A. M. (2015) · Journal of Advanced Research · doi:10.1016/j.jare.2014.11.008 · Cited by 319
Zhou, S.-F., Wang, L.-L., Di, Y., Xue, C., Duan, W., Li, C., & Li, Y. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785132870 · Cited by 318
Pan, Y.-Z., Morris, M. E., & Yu, A.-M. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054163 · Cited by 309
Human ABCG2: structure, function, and its role in multidrug resistance.
Mo, W., & Zhang, J. (2012) · PubMed · Cited by 305
Collateral sensitivity as a strategy against cancer multidrug resistance
Pluchino, K. M., Hall, M. D., Goldsborough, A. S., Callaghan, R., & Gottesman, M. M. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.03.002 · Cited by 305
Bao, L., Hazari, S., Mehra, S., Kaushal, D., Moroz, K., & Dash, S. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.024 · Cited by 275
Multidrug resistance: Physiological principles and nanomedical solutions
Kunjachan, S., Rychlik, B., Storm, G., Kiessling, F., & Lammers, T. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.018 · Cited by 259
MicroRNAs in human cancer: from research to therapy
Negrini, M., Ferracin, M., Sabbioni, S., & Croce, C. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.03450 · Cited by 239
Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition
Jedlitschky, G., Hoffmann, U., & Kroemer, H. K. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.3.351 · Cited by 238
The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy
Wu, C.-P., Hsieh, C.-H., & Wu, Y.-S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200261n · Cited by 234
Cripe, L. D., Uno, H., Paietta, E. M., Litzow, M. R., Ketterling, R. P., Bennett, J. M., Rowe, J. M., Lazarus, H. M., Luger, S., & Tallman, M. S. (2010) · Blood · doi:10.1182/blood-2010-04-277269 · Cited by 233
Evers, R., de Haas, M., Sparidans, R., Beijnen, J., Wielinga, P. R., Lankelma, J., & Borst, P. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1262 · Cited by 227
Pluronics and MDR reversal: an update
Alakhova, D. Y., & Kabanov, A. V. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500298q · Cited by 224
Pharmacokinetic and Pharmacodynamic Implications of P‐glycoprotein Modulation
Matheny, C. J., Lamb, M. W., Brouwer, K. L. R., & Pollack, G. M. (2001) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.9.778.34558 · Cited by 222
Histone deacetylase 10 promotes autophagy-mediated cell survival
Oehme, I., Linke, J.-P., Böck, B. C., Milde, T., Lodrini, M., Hartenstein, B., Wiegand, I., Eckert, C., Roth, W., Kool, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300113110 · Cited by 221
Role of transporters in drug interactions
Han, H.-K. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-1107-y · Cited by 220
Mammalian multidrug-resistance proteins (MRPs)
Slot, A. J., Molinski, S. V., & Cole, S. P. C. (2011) · Essays in Biochemistry · doi:10.1042/bse0500179 · Cited by 218
Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents
Fojo, T., & Menefee, M. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm172 · Cited by 217
Membrane Topology and Glycosylation of the Human Multidrug Resistance-associated Protein
Bakos, É., Hegedüs, T., Holló, Z., Welker, E., Tusnády, G. E., Zaman, G. J. R., Flens, M. J., Váradi, A., & Sarkadi, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12322 · Cited by 211
Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
K. Tiwari, A., Sodani, K., Dai, C.-L., R. Ashby, C., & Chen, Z.-S. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795164048 · Cited by 211
Self-citationXu, Y., Xia, F., Ma, L., Shan, J., Shen, J., Yang, Z., Liu, J., Cui, Y., Bian, X., Bie, P., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.06.027 · Cited by 210
Tiwari, A. K., Sodani, K., Wang, S.-R., Kuang, Y.-H., Ashby, C. R., Chen, X., & Chen, Z.-S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.002 · Cited by 209
Self-citationBattle, T. E., Arbiser, J., & Frank, D. A. (2005) · Blood · doi:10.1182/blood-2004-11-4273 · Cited by 206
Zhang, X.-W., Bu, P., Liu, L., Zhang, X.-Z., & Li, J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.121 · Cited by 202
Self-citationMolecular Pathways: Regulation and Therapeutic Implications of Multidrug Resistance
Chen, K. G., & Sikic, B. I. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1590 · Cited by 197
Singh, A., Wu, H., Zhang, P., Happel, C., Ma, J., & Biswal, S. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0108 · Cited by 192
ABCG2 expression, function, and promoter methylation in human multiple myeloma
Turner, J. G., Gump, J. L., Zhang, C., Cook, J. M., Marchion, D., Hazlehurst, L., Munster, P., Schell, M. J., Dalton, W. S., & Sullivan, D. M. (2006) · Blood · doi:10.1182/blood-2005-10-009084 · Cited by 189
The role of ABC transporters in ovarian cancer progression and chemoresistance
Ween, M. P., Armstrong, M. A., Oehler, M. K., & Ricciardelli, C. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.05.012 · Cited by 181
The role of transporters in drug interactions
Endres, C. J., Hsiao, P., Chung, F. S., & Unadkat, J. D. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.002 · Cited by 179
Feng, D., Zhang, H., Zhang, P., Zheng, Y., Zhang, X., Han, B., Luo, X., Xu, L., Zhou, H., Qu, L., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01213.x · Cited by 175
Kelly, R. J., Draper, D., Chen, C. C., Robey, R. W., Figg, W. D., Piekarz, R. L., Chen, X., Gardner, E. R., Balis, F. M., Venkatesan, A. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1725 · Cited by 172
MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN
Wang, F., Li, T., Zhang, B., Li, H., Wu, Q., Yang, L., Nie, Y., Wu, K., Shi, Y., & Fan, D. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.010 · Cited by 170
Minderman, H., O’Loughlin, K. L., Pendyala, L., & Baer, M. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0914-3 · Cited by 170
The UCSF-FDA TransPortal: A Public Drug Transporter Database
Morrissey, K. M., Wen, C. C., Johns, S. J., Zhang, L., Huang, S.-M., & Giacomini, K. M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.44 · Cited by 169
Self-citationLim, J. C., Kania, K. D., Wijesuriya, H., Chawla, S., Sethi, J. K., Pulaski, L., Romero, I. A., Couraud, P. O., Weksler, B. B., Hladky, S. B., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05537.x · Cited by 164
Hellebrekers, D. M. E. I., Castermans, K., Viré, E. A., Dings, R. P. M., Hoebers, N., Mayo, K. H., Egbrink, M. G. A. O., Molema, G., Fuks, F., van Engeland, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1609 · Cited by 161
Diversity in ABC transporters: Type I, II and III importers
Rice, A. J., Park, A., & Pinkett, H. W. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2014.953626 · Cited by 160
Kawabe, T., Chen, Z.-S., Wada, M., Uchiumi, T., Ono, M., Akiyama, S.-I., & Kuwano, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00979-5 · Cited by 158
Self-citationABCC2/Abcc2: a multispecific transporter with dominant excretory functions
Jemnitz, K., Herédi‐Szabó, K., Jánossy, J., Ioja, E., Vereczkey, L., & Krajcsi, P. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903491741 · Cited by 152
Kolitz, J. E., George, S. L., Dodge, R. K., Hurd, D. D., Powell, B. L., Allen, S. L., Vélez-García, E., Moore, J. O., Shea, T. C., Hoke, E. E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.106 · Cited by 150
Wang, Y., Zhang, D., Wu, K., Zhao, Q., Nie, Y., & Fan, D. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01580-13 · Cited by 148
Yhee, J. Y., Song, S.-Y., Lee, S. J., Park, S.-G., Kim, K., Kim, M. G., Son, S., Koo, H., Kwon, I. C., Jeong, S. Y., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.019 · Cited by 140
Martín, V., Sánchez‐Sánchez, A. M., Herrera, F., Gomez‐Manzano, C., Fueyo-Margareto, J., Vega, M. A. Á., Antolín, I., & Rodríguez, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.188 · Cited by 133
Purification and 3D Structural Analysis of Oligomeric Human Multidrug Transporter ABCG2
McDevitt, C. A., Collins, R. F., Conway, M. A., Modok, S., Storm, J., Kerr, I. D., Ford, R. C., & Callaghan, R. (2006) · Structure · doi:10.1016/j.str.2006.08.014 · Cited by 132
Chearwae, W., Shukla, S., Limtrakul, P., & Ambudkar, S. V. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0087 · Cited by 130
Kolitz, J. E., George, S. L., Marcucci, G., Vij, R., Powell, B. L., Allen, S. L., DeAngelo, D. J., Shea, T. C., Stock, W., Baer, M. R., et al. (2010) · Blood · doi:10.1182/blood-2009-07-229492 · Cited by 129
Tiwari, A. K., Sodani, K. S., Dai, C.-L., Abuznait, A. H., Singh, S., Xiao, Z., Patel, A. S., Talele, T. T., Fu, L., Kaddoumi, A., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.001 · Cited by 128
Self-citationMilane, L. S., Ganesh, S., Shah, S., Duan, Z., & Amiji, M. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.032 · Cited by 128
Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
Anreddy, N., Gupta, P., Kathawala, R. J., Patel, A. S., Wurpel, J. N. D., & Chen, Z. (2014) · Molecules · doi:10.3390/molecules190913848 · Cited by 126
Self-citationTo, K. K. W., Polgár, O., Huff, L. M., Morisaki, K., & Bates, S. E. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0175 · Cited by 125
Non-coding RNAs: An emerging player in DNA damage response
Zhang, C., & Peng, G. (2014) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.11.003 · Cited by 124
(-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line
Farabegoli, F., Papi, A., Bartolini, G., Ostan, R., & Orlandi, M. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.01.001 · Cited by 123
Chen, Z., Ma, T., Huang, C. Z., Zhang, L., Lv, X., Xu, T., Hu, T., & Li, J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.032 · Cited by 122
Self-citationNies, A. T., Schwab, M. G., & KEPPLER, D. O. R. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.5.545 · Cited by 122
Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia
Corrêa, S., Binato, R., Rocher, B. D., Castelo-Branco, M. T. L., Pizzatti, L., & Abdelhay, E. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-303 · Cited by 116
Zhang, H., Zhang, X., Wu, X., Li, W., Su, P., Cheng, H., Xiang, L., Gao, P., & Zhou, G. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.039 · Cited by 116
Zhu, X., Li, Y., Xie, C., Yin, X., Liu, Y., Cao, Y., Fang, Y., Lin, X., Xu, Y., Xu, W., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28774 · Cited by 114
Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer
Ivanova, T., Zouridis, H., Wu, Y., Cheng, L. L., Tan, I. B., Gopalakrishnan, V., Ooi, C.-H., Lee, J., Qin, L., Wu, J., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301113 · Cited by 114
Keshelava, N., Davicioni, E., Wan, Z., Ji, L., Sposto, R., Triche, T. J., & Reynolds, C. P. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm044 · Cited by 108
Wakai (2010) · Oncology Reports · doi:10.3892/or_00000721 · Cited by 108
Hauswald, S., Duque‐Afonso, J., Wagner, M. M., Schertl, F. M., Lübbert, M., Peschel, C., Keller, U. B., & Licht, T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2048 · Cited by 107
Tabe, Y., Konopleva, M. Y., Contractor, R., Munsell, M. F., Schober, W. D., Jin, L., Tsutsumi‐Ishii, Y., Nagaoka, I., Igari, J., & Andreeff, M. (2005) · Blood · doi:10.1182/blood-2004-10-4126 · Cited by 106
Jiao, X., Zhao, L., Ma, M., Bai, X., He, M., Yan, Y., Wang, Y., Chen, Q., Zhao, X., Zhou, M., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2607-x · Cited by 106
Shen, D., Zhang, W., Zeng, X., & Liu, C. (2013) · Cancer Science · doi:10.1111/cas.12223 · Cited by 106
Ma, M., He, M., Wang, Y., Jiao, X., Zhao, L., Bai, X., Yu, Z., Wu, H., Sun, M., Song, Z. J., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.016 · Cited by 105
Rost, D., König, J., Weiß, G., Klar, E., Stremmel, W., & KEPPLER, D. O. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.28648 · Cited by 101
Janneh, O., Jones, E., Chandler, B., Owen, A., & Khoo, S. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm353 · Cited by 101
Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol
Xu, D., Lu, Q., & Hu, X. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.11.031 · Cited by 99
Zhao, B., Sun, Y., Wang, S., Duan, L., Huo, Q.-L., Ren, F., & Li, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071071 · Cited by 91
Sui, H. X., Zhou, S., Wang, Y., Liu, X., Zhou, L., Yin, P., Fan, Z., & Li, Q. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr016 · Cited by 91
Gandhi, L., Harding, M. W., Neubauer, M., Langer, C. J., Moore, M., Ross, H. J., Johnson, B. E., & Lynch, T. J. (2007) · Cancer · doi:10.1002/cncr.22492 · Cited by 90
Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics
Jani, M., Temesszentandrási‐Ambrus, C., Magnan, R., Jakab, K. T., Beéry, E., Zolnerciks, J. K., & Krajcsi, P. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1224-8 · Cited by 86
To, K. K. W. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-99 · Cited by 79
Takwi, A., Wang, Y.-M., Wu, J., Michaelis, M., Cinatl, J., & Chen, T.-S. (2013) · Oncogene · doi:10.1038/onc.2013.330 · Cited by 79
Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma.
Fan, T.-Y., Wang, H., Peng, X., Liu, Y., Li, H., Lei, B., Yu, M., & Qi, S. (2014) · PubMed Central · Cited by 76
Choi, B.-H., Ryoo, I.-G., Kang, H. C., & Kwak, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107158 · Cited by 70
Collett, G. P. (2001) · Carcinogenesis · doi:10.1093/carcin/22.5.821 · Cited by 70
Bramwell, V. H. C., Morris, D. G., Ernst, D. S., Hings, I. M., Blackstein, M. E., Venner, P. M., Ette, E., Harding, M. W., Waxman, A. J., & Demetri, G. D. (2002) · PubMed · Cited by 59
Bark, H., & Choi, C.-H. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1121-7 · Cited by 58
Bhatia, P., Bernier, M., Sanghvi, M., Moaddel, R., Schwarting, R., Ramamoorthy, A., & Wainer, I. W. (2012) · Xenobiotica · doi:10.3109/00498254.2012.662726 · Cited by 58
Nabekura, T., Yamaki, T., & Kitagawa, S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.025 · Cited by 56
Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer
Miao, Y. (2011) · Oncology Reports · doi:10.3892/or.2011.1475 · Cited by 55
Accurate Models for P-gp Drug Recognition Induced from a Cancer Cell Line Cytotoxicity Screen
Levatić, J., Ćurak, J., Kralj, M., Šmuc, T., Osmak, M., & Supek, F. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400328s · Cited by 55
Rochat, B. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909789056999 · Cited by 54
Capobianco, E., Mora, A., Sala, D. L., Roberti, A., Zaki, N., Badidi, E., Taranta, M., & Cinti, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095596 · Cited by 51
Marine Natural Products as Breast Cancer Resistance Protein Inhibitors
Chérigo, L., Lopéz, D., & Martínez‐Luis, S. (2015) · Marine Drugs · doi:10.3390/md13042010 · Cited by 51
Sodani, K. S., Patel, A. S., Anreddy, N., Singh, S., Yang, D., Kathawala, R. J., Kumar, P., Talele, T. T., & Chen, Z. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.02.012 · Cited by 47
Self-citationTomiyasu, H., Goto‐Koshino, Y., Fujino, Y., Ohno, K., & Tsujimoto, H. (2013) · The Veterinary Journal · doi:10.1016/j.tvjl.2013.10.022 · Cited by 47
Prouillac, C., Videmann, B., Mazallon, M., & Lecoeur, S. (2009) · Toxicology · doi:10.1016/j.tox.2009.06.023 · Cited by 45
Human P-glycoprotein Contains a Greasy Ball-and-Socket Joint at the Second Transmission Interface
Loo, T. W., Bartlett, M. C., & Clarke, D. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.484550 · Cited by 44
Wang, D., Patel, A. S., Shukla, S., Zhang, Y.-K., Wang, Y.-J., Kathawala, R. J., Robey, R. W., Zhang, L., Yang, D., Talele, T. T., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2102 · Cited by 43
Self-citationKim (2010) · International Journal of Oncology · doi:10.3892/ijo.2010.879 · Cited by 43
A reciprocating twin-channel model for ABC transporters
Jones, P. M., & George, A. M. (2014) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583514000031 · Cited by 43
Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance
Li, S., Zhang, W., Yin, X., et al. (2015) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520615666150129212723 · Cited by 43
Villar, V. H., Vögler, O., Martínez-Serra, J., Ramos, R. F., Fariñas, S. C., Gutierrez, A. M., Barceló, F., Martín‐Broto, J., & Alemany, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037735 · Cited by 41
Wei, N., Sun, H., Wang, F., & Liu, G.-T. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1397-7 · Cited by 41
Daenen, S. M. G. J., van der Holt, B., Verhoef, G. E. G., Löwenberg, B., Wijermans, P., Huijgens, P. C., Kooy, R. V. M., Schouten, H. C., Kramer, M. H. H., Ferrant, A., et al. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.03.001 · Cited by 40
Fedier, A., Dedes, K. J., Imesch, P., von Bueren, A. O., & Fink, D. A. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.3.633 · Cited by 38
Brand, W., Oosterhuis, B., Krajcsi, P., Barron, D., Dionisi, F., van BLADEREN, P. J., Rietjens, I. M. C. M., & Williamson, G. (2011) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.780 · Cited by 37
Zhang, K., Song, H., Yang, P., Dai, X., Li, Y., Wang, L., Du, J., Pan, K., & Zhang, T. (2015) · Cell Proliferation · doi:10.1111/cpr.12161 · Cited by 34
Histone deacetylase inhibitor apicidin-mediated drug resistance: Involvement of P-glycoprotein
Kim, Y. K., Kim, N. H., Hwang, J. W., Song, Y.-J., Park, Y.-S., Seo, D. W., Lee, H. Y., Choi, W. S., Han, J., & Kim, S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.013 · Cited by 33
Loss of runt‐related transcription factor 3 induces gemcitabine resistance in pancreatic cancer
Horiguchi, S., Shiraha, H., Nagahara, T., Kataoka, J., Iwamuro, M., Matsubara, M., Nishina, S., Kato, H., Takaki, A., Nouso, K., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.04.004 · Cited by 33
Herédi‐Szabó, K., Glavinas, H., Kis, E.-É., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023895 · Cited by 32
O'Brien, M. M., Lacayo, N. J., Lum, B. L., Kshirsagar, S. A., Buck, S. A., Ravindranath, Y., Bernstein, M. L., Weinstein, H. J., Chang, M. N., Arceci, R. J., et al. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22366 · Cited by 30
Shilton, B. H. (2015) · Biochemical Journal · doi:10.1042/bj20140675 · Cited by 26
Yatouji, S., El‐Khoury, V., Trentesaux, C., Trussardi‐Régnier, A., Benabid, R., Bontems, F., & Dufer, J. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.4.1003 · Cited by 24
Saito, J., Hirota, T., Furuta, S., Kobayashi, D., Takane, H., & Ieiri, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072906 · Cited by 23
Methylation of SFRP5 is related to multidrug resistance in leukemia cells
Wang, H., Wang, X., Hu, R., Yang, W., Liao, A., Zhao, C., Zhang, J., & Liu, Z. (2014) · Cancer Gene Therapy · doi:10.1038/cgt.2013.87 · Cited by 21
Modulating Drug Resistance by Targeting BCRP/ABCG2 Using Retrovirus-Mediated RNA Interference
Xie, N., Mou, L., Yuan, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103463 · Cited by 21
Hung, C., & Liou, H. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9496-1 · Cited by 19
Cited by
Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects
Begines, B., Ortiz, T., Pérez-Aranda, M., Martínez, G., Merinero, M., Argüelles-Arias, F., & Alcudia, A. (2020) · Nanomaterials · doi:10.3390/nano10071403 · Cited by 1,061
Targeting non-coding RNAs to overcome cancer therapy resistance
Chen, B., Dragomir, M. P., Yang, C., Li, Q., Horst, D., & Calin, G. A. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00975-3 · Cited by 435
Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence
Lin, S., Chang, C., Hsu, C., Tsai, M., Cheng, H., Leong, M. K., Sung, P., Chen, J., & Weng, C. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14816 · Cited by 425
Natural products as multidrug resistance modulators in cancer
Kumar, A., & Jaitak, V. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.027 · Cited by 334
Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance
Bar-Zeev, M., Livney, Y. D., & Assaraf, Y. G. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.05.002 · Cited by 314
Metadata
- Authors
- Chen, Z., Shi, T., Zhang, L., Zhu, P., Deng, M., Huang, C., Hu, T., Jiang, L., & Li, J.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 370
- Issue
- 1
- Pages
- 153-164
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2174049160
- Cited by
- 729
- References
- 145
- FWCI
- 24.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.